Cormorant Asset Management, Lp's Net Worth
Cormorant Asset Management, Lp's net worth is estimated to be at least $156,330,002.89 as of 05/03/2024. CoreStreet's estimation of Cormorant Asset Management, Lp's net worth is based on their sale of stock and current holding of stock.
Cormorant Asset Management, Lp is Major Shareholder at Eyepoint Pharmaceuticals Inc. They have executed at least 17 trades of stock as per SEC Form 4 filings. Their most recent trade was for 581,765 units of EYPT stock on 04/18/2024. Their biggest sale was on 03/14/2024 when they sold 509,091 units of Immuneering Corp stock for $1,893,818.52. They typically trade 3 times per year.
Total value of insider buys:
- $153,276,184.37
Total value of insider sells:
- $3,053,818.52
Most recent insider trade:
- April 18, 2024
Cormorant Asset Management, Lp's Insider Trading History
| Eyepoint Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 18, 2024 | Major Shareholder | 581,765 | $18.03 | Buy | $10,489,222.95 |
Jan. 11, 2024 | Major Shareholder | 750,000 | $19.75 | Buy | $14,812,500.00 |
Jan. 9, 2024 | Major Shareholder | 105,000 | $21.32 | Buy | $2,238,600.00 |
Dec. 8, 2023 | Major Shareholder | 588,235 | $17.00 | Buy | $9,999,995.00 |
Dec. 4, 2023 | Major Shareholder | 1,919,057 | $21.82 | Buy | $41,873,823.74 |
| Immuneering Corp | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 1, 2024 | Major Shareholder | 400,000 | $2.90 | Sell | $1,160,000.00 |
March 14, 2024 | Major Shareholder | 509,091 | $3.72 | Sell | $1,893,818.52 |
| Corbus Pharmaceuticals Holding | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 7, 2024 | Major Shareholder | 250,000 | $40.05 | Buy | $10,012,500.00 |
Feb. 2, 2024 | Major Shareholder | 750,000 | $19.00 | Buy | $14,250,000.00 |
Jan. 26, 2024 | Major Shareholder | 282,632 | $32.24 | Buy | $9,112,055.68 |
| Ambrx Biopharma Inc ADR | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 16, 2023 | Major Shareholder | 500,000 | $10.15 | Buy | $5,075,000.00 |
March 14, 2023 | Major Shareholder | 250,000 | $9.95 | Buy | $2,487,500.00 |
| Bioatla Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 18, 2020 | Major Shareholder | 800,000 | $18.00 | Buy | $14,400,000.00 |
| Olema Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 23, 2020 | Major Shareholder | 425,000 | $19.00 | Buy | $8,075,000.00 |
| Turning Point Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 22, 2019 | Major Shareholder | 400,000 | $18.00 | Buy | $7,200,000.00 |
| Axonics Modulation Technologies Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 31, 2018 | Major Shareholder | 133,333 | $15.00 | Buy | $1,999,995.00 |
| Kiniksa Pharmaceuticals Ltd | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 29, 2018 | Major Shareholder | 69,444 | $18.00 | Buy | $1,249,992.00 |